Alternatives to NovoCare Pharmacy

It prices Ozempic and Zepbound at $1,399 and $1,599, which almost nobody here does. The compounded line is “from” $49 — under a dated sale, and billed every four weeks.

A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included partner if you can live with a yearly plan and a pharmacy it doesn't name.

The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.

LifeMD's medication prices are clear and its program fee is not. Read live on 2026-08-26, one page states that fee three different ways: a footnote says the monthly program and provider fee is $149 with a first month discounted to $39, two separate blocks say the program fee starts at $75, and a pricing panel shows $29 a month for members against a per-visit label. Those cannot all be true, and none of them buys medication — the page repeats that medication cost is not included and varies with insurance or self-pay. On the medication side it is more useful: $199 a month for the Wegovy pen and $149 for the Wegovy pill, both footnoted as initial pricing for new patients eligible without insurance coverage, and $349 a month for a Zepbound vial with no such qualifier. Insurance is the intended route, with an advertised average approved copay of $0 to $25, which is either the cheapest option here or no option at all depending on your plan. What it does disclose well is coverage: it describes itself as a 50-state direct-to-patient telehealth company with a 50-state medical group. It also advertises a refund if you do not lose 10 percent of your body weight in a year, with terms that live behind a link rather than on the page.

GoodRx now runs a real prescriber, not just a coupon, and the two should not be confused. GoodRx Care Direct charges $39 a month for unlimited online care and bills the medication separately — read live on 2026-08-26, it lists the Wegovy pill as low as $149 a month, the Wegovy and Wegovy HD pens as low as $199 and the Zepbound KwikPen as low as $299, all under the label only FDA-approved medications, with no compounded tier at all. Every one of those is an as low as rather than a rate, so treat them as the bottom of a dose ladder. One thing here is better than almost anything else on this list for a working parent: GoodRx says a visit with a healthcare professional takes place via text, call or video, which means a text-only path exists. One thing is worse, and it belongs in the open. In February 2023 the Department of Justice, acting for the Federal Trade Commission, filed a complaint and a stipulated order in the Northern District of California, and GoodRx Holdings, Inc. agreed to a $1.5 million civil penalty over allegations that it shared users' prescription and health information with advertising platforms contrary to its own privacy promises; the order permanently bars it from disclosing user health information for advertising, and the case caption names GoodRx Care, the service reviewed here. That is a data question rather than a medicine question, and it is exactly the kind of thing worth knowing before you type your health history into a form.

Ro runs two meters and only one of them is the price you see first. The Ro Body membership is $39 for a first month and then $149 a month if you stay month to month, falling to $99, $89 or $74 only if you prepay three, six or twelve months up front. The medication is billed separately, and Ro's own FAQ says so: the cost of GLP-1 medication is not included in the membership cost. On the medication side it publishes a genuinely detailed cash ladder — $349 a month for the Wegovy pen at maintenance doses and $399 at the 7.2 mg high dose, $299 for Zepbound at 2.5 mg climbing to $449 from 7.5 mg up, and $149 for the daily Wegovy pill at its starting dose. Everything here is FDA-approved brand product rather than compounded, which is the real reason to look at Ro and also the reason nothing on the menu is cheap. Two of the advertised rates are limited-time offers with sign-up deadlines printed on the page. It publishes something most of this roster does not — a stated turnaround, with eligibility answered within 2 days and a first cash-pay dose in under a week — but it publishes no state list anywhere we could find, and it never says whether the intake is asynchronous or needs a scheduled video visit.

A high-volume general telehealth platform, not a GLP-1 specialist — $99 flat for a one-time doctor consultation with no membership, but the medication cost is billed separately and never itemized, so the real monthly total is unknown until you fill the prescription.

The arithmetic here is unusually easy to do, because ZipHealth publishes a price for every dose — and unusually easy to get wrong, because none of those prices includes the $79 clinical service and support fee. The FAQ says that fee applies to new and repeat patients, so it recurs. Cheapest genuine month: $149 + $79 = $228. Zepbound at 7.5mg and above: $449 + $79 = $528. What you get for it is the FDA-approved drug rather than a compounded version — there is no compounding here at all.

An established longevity-telehealth brand with a microdose-first GLP-1 menu — starting at $99/mo microdosing semaglutide, $159/mo microdosing tirzepatide — plus brand-name Wegovy/Zepbound access-and-monitoring for a separate $50–$65 fee (drug cost billed apart).